About: Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.87 (-1.78%)
UNCY NASDAQ Unicycive Therapeutics Inc
Unicycive Therapeutics Inc share price
UNCY price activity
Last Price
$3.870
Change (24hr)
-0.07 USD (1.78%)
Volume
1.08M
Volume (4w avg)
-
Open
$3.95
Day Range
$3.71 - $4.02
Previous Close
$3.94
Last Trade
23 Oct, 6:49 pm GMT+0
Delayed
23 Oct, 6:49 pm GMT+0
UNCY price performance
Delayed
23 Oct, 6:49 pm GMT+0
UNCY Market Signals